Funds holding Middle East Pharmaceutical Co
ISIN SA160G51UO10 · Saudi Arabia
- Fund holders
- 15
- Of which ETFs
- 7 8 other funds
- Value held
- 2.1M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| iShares MSCI Saudi Arabia ETF iShares Trust | 23,184 | 643.7K $ | 0.10 % | as of Feb 28, 2026 ↗ |
| WisdomTree Emerging Markets SmallCap Dividend Fund WisdomTree Trust | 21,309 | 553.4K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 8,527 | 233.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 5,196 | 134.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional Emerging Core Equity Market ETF Dimensional ETF Trust | 4,890 | 133.6K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 4,038 | 104.9K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| State Street Global All Cap Equity ex-U.S. Index Portfolio STATE STREET INSTITUTIONAL INVESTMENT TRUST | 2,755 | 71.5K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 2,042 | 55.9K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 1,442 | 39.4K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO | 1,394 | 38.1K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Emerging Markets Equity ETF American Century ETF Trust | 1,108 | 30.8K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional Emerging Markets ex China Core Equity ETF Dimensional ETF Trust | 648 | 17.7K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Emerging Markets ex China Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 396 | 10.8K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 383 | 10.5K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Markets Sustainability Core 1 ETF Dimensional ETF Trust | 326 | 8.9K $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares MSCI Saudi Arabia ETF iShares Trust | 0.10 % | as of Feb 28, 2026 ↗ |
| WisdomTree Emerging Markets SmallCap Dividend Fund WisdomTree Trust | 0.03 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.02 % | as of Mar 31, 2026 ↗ |
| Dimensional Emerging Markets ex China Core Equity ETF Dimensional ETF Trust | 0.01 % | as of Apr 30, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Core Equity Market ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Markets Sustainability Core 1 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| THE EMERGING MARKETS SMALL CAP SERIES DFA INVESTMENT TRUST CO | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets ex China Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 15 | +2 | 77,638 | +11.3 % |
| 2026Q1 | 13 | +3 | 69,766 | +125.2 % |
| 2025Q4 | 10 | +5 | 30,986 | +26.4 % |
| 2025Q3 | 5 | +1 | 24,515 | +9.1 % |
| 2025Q2 | 4 | 0 | 22,478 | +13.7 % |
| 2025Q1 | 4 | 0 | 19,778 | +2.3 % |
| 2024Q4 | 4 | +2 | 19,334 | +50.3 % |
| 2024Q3 | 2 | 12,863 |
Cite this page
Titelia. "Funds holding Middle East Pharmaceutical Co". https://titelia.com/en/stocks/middle-east-pharmaceutical-co-SA160G51UO10